Recombinant NCAM1 (Lorvotuzumab Biosimilar) antibody
The Humanized Chimeric anti-NCAM1 (Lorvotuzumab Biosimilar) antibody has been validated for not_set. It is suitable to detect NCAM1 (Lorvotuzumab Biosimilar) in samples from Human.
Catalog No. ABIN7597798
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant NCAM1 (Lorvotuzumab Biosimilar) antibody (ABIN7597798)
Target
NCAM1 (Lorvotuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This NCAM1 (Lorvotuzumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Lorvotuzumab Biosimilar Antibody
-
Specificity
- NCAM-1, NCAM1, CD56, N-CAM-1, NCAM, Neural cell adhesion molecule 1
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
anti-NCAM1 (Lorvotuzumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- NCAM1 (Lorvotuzumab Biosimilar)
-
Alternative Name
- Lorvotuzumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- NCAM-1, NCAM1, CD56, N-CAM-1, NCAM, Neural cell adhesion molecule 1
-
UniProt
- P13591
-
CAS-No
- 1008106-64-6
Target
-
You are here:
